首页 > 市场调查报告书 > 医疗设备

眼科设备

市场调查报告书

商品编码

1634177

全球眼科包装市场 - 2025 - 2033

Global Ophthalmology Packaging Market - 2025 - 2033

出版日期: 2025年01月13日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球眼科包装市场2024年达到125亿美元，预计2033年将达278亿美元，2025-2033年预测期间复合年增长率为9.7%。

眼科包装是指为药物、医疗器材和手术器械等眼部护理产品设计的专业包装解决方案。该领域包括包装材料的设计、製造和分销，以确保眼科产品在其整个生命週期中的安全性、无菌性和完整性。眼科包装的主要目的是保护眼科药物和器械的无菌性。由于许多眼科处方产品是局部或眼内给药的，任何污染都可能导致重大健康危害，包括感染和有害反应。

眼科包装的需求不断增长是预测期内推动市场的驱动因素。随着眼部疾病数量的增加，对眼药水的需求增加，对眼科包装的需求也增加。例如，根据美国国立卫生研究院的数据，全球估计有 2 亿人患有 AMD，到 2040 年，这一数字预计将增加到接近 3 亿人。到 2050 年，预计将有 540 万美国人受到与此类似的上升模式的影响。

市场动态：

驱动程式和限制

眼科包装需求不断增加

对眼科包装的需求不断增长预计将成为全球眼科市场成长的重要因素。这一增长是由多种因素推动的，包括眼病率的增加、药物传输技术的进步、电子商务的增长以及向无防腐剂配方的转变、最近的产品发布和批准。

随着患有青光眼、白内障和老年黄斑部病变等各种眼部疾病的人数不断增加，对保护产品完整性和患者安全的有效、安全的包装解决方案的需求也在增加。例如，根据青光眼研究基金会的数据，全球估计有 8,000 万人患有青光眼。最有趣的是，超过一半的青光眼患者不知道自己的病情。超过 300 万美国人患有青光眼，其中超过一半不知道自己患有青光眼。人的寿命越长，青光眼的可能性就越大。据信，2010 年，原发性开角型青光眼已导致全球 840 万人失明。

此外，智慧包装技术的进步已经改变了眼科包装的面貌。 RFID 和二维码整合提高了可追溯性和安全性，从而能够更准确地监控整个分销过程中的产品状况。这些技术不仅提高了患者对药物治疗方案的依从性，而且还满足了对药品供应链透明度和责任不断增长的监管要求。

电子商务的发展是推动眼科包装成长的另一个重要因素。随着越来越多的人转向网路药局寻求眼部护理，迫切需要安全、防篡改和防漏的包装解决方案。製造商正在透过发明客製化包装来应对这一趋势，这些包装可以承受直接面向消费者的运输的严格要求，同时确保产品在交付后保持安全和功能。

生产成本高

高生产成本等因素预计将阻碍全球眼科包装市场。为了确保产品的安全性和有效性，眼科包装製造商必须使用创新材料和技术。这些严格的品质标准经常导致更高的生产成本，这对于缺乏财力来参与复杂製造程序的小型企业来说尤其困难。因此，高生产成本可能会限制市场准入和竞争力，阻碍产业的整体成长和创新。眼科包装的平均製造成本估计在每单位 0.05 美元到 0.50 美元之间，具体取决于包装设计和所用材料的复杂性。例如，简单的塑胶滴管瓶可能处于此范围的低端，但使用智慧技术或专业材料的更先进的设计可能会更昂贵。

Ophthalmology packaging refers to specialized packaging solutions designed for eye care products such as medications, medical devices, and surgical instruments. This field includes the design, manufacture, and distribution of packaging materials that assure the safety, sterility, and integrity of ophthalmic products throughout their life cycle. The major purpose of ophthalmic packaging is to protect the sterility of eye drugs and devices. Because many ophthalmic prescription products are delivered topically or intraocularly, any contamination might result in major health hazards, including infections and harmful reactions.

The increasing demand for ophthalmology packaging is the driving factor that drives the market over the forecast period. As the number of ocular disorders increases, the demand for the eye drops increases and the demand for the ophthalmology packaging also increases. For instance, according to the National Institute of Health, 200 million people worldwide are estimated to have AMD, and by 2040, this number is projected to rise to close to 300 million. By 2050, 5.4 million Americans are anticipated to be affected by rising patterns similar to this one.

Market Dynamics: Drivers & Restraints

Increasing demand for ophthalmology packaging

The increasing demand for ophthalmology packaging is expected to be a significant factor in the growth of the global ophthalmology market. This growth is driven by a number of factors, including an increase in the prevalence of eye diseases, advances in medication delivery technologies, increase in the e-commerce and a shift toward preservative-free formulation, recent product launches and approvals.

As the number of people suffering from various eye disorders including glaucoma, cataracts, and age-related macular degeneration grows, so does the demand for effective and safe packaging solutions that protect product integrity and patient safety. For instance, aaccording to the Glaucoma Research Foundation, glaucoma affects an estimated 80 million individuals globally. Most interestingly, over half of all glaucoma patients are unaware of their condition. More than 3 million Americans suffer from glaucoma, and over half of them are unaware of their condition. The longer someone lives, the more likely they are to develop glaucoma. Primary open-angle glaucoma is believed to have blinded 8.4 million people around the world in 2010. By 2040, it is anticipated that 22 million people will be blind due to glaucoma.

Furthermore, advances in smart packaging technologies have transformed the face of ophthalmic packaging. RFID and QR code integration improve traceability and safety, enabling for more accurate monitoring of product conditions throughout the distribution process. These technologies not only increase patient adherence to drug regimens, but they also align with rising regulatory demands for transparency and responsibility in pharmaceutical supply chains.

The development of e-commerce is another important element driving the increase of ophthalmic packaging. As more people turn to online pharmacies for eye care, there is an urgent need for secure, tamper-evident, and leak-proof packaging solutions. Manufacturers are responding to this trend by inventing customized packaging that can resist the rigors of direct-to-consumer shipping while guaranteeing that products stay safe and functional once delivered.

High production costs

Factors such as high production costs are expected to hamper the global ophthalmology packaging market. To assure product safety and efficacy, ophthalmic packaging manufacturers must use innovative materials and technology. These severe quality criteria frequently result in higher production costs, which can be especially difficult for smaller businesses who lack the financial resources to engage in complex manufacturing procedures. As a result, high production costs might limit market access and competitiveness, impeding overall growth and innovation in the industry. The average manufacturing costs for ophthalmic packaging are estimated to range between $0.05 and $0.50 per unit, depending on the complexity of the package design and materials utilized. Simple plastic dropper bottles, for example, may be on the lower end of this spectrum, but more advanced designs that use smart technology or specialist materials may be more expensive.

Segment Analysis

The global ophthalmology packaging market is segmented based on packaging type, application, indication, dosage, material, end-user, and region.

Eye Drops segment is expected to dominate the global ophthalmology packaging market share

Several compelling factors are anticipated to drive the global ophthalmology packaging market, with eye drops leading among them such as increasing prevalence of ocular disorders, recent product launches and approvals and technological advancements. As one of the most regularly used types of medication for a variety of eye problems, eye drops necessitate specific packaging solutions that assure sterility, ease of use, and precise dosing. The rising prevalence of eye illnesses such as glaucoma, dry eye syndrome, and allergies has fueled demand for effective treatments, resulting in an increase in ophthalmic product manufacture and distribution, notably eye drops. This trend is prominent in the significant market share for this sector, which is expected remain consistent as healthcare practitioners and patients rely more on these formulations to manage eye health.

For instance, according to the World Health Organization, cataracts affect approximately 65.2 million people and cause moderate to severe vision loss in over 80% cases. Cataract is responsible for over 51% of blindness in the Eastern Mediterranean Region. Moreover, according to the UH Hospitals, an estimated 3.2 million women age 50 and over, and 1.68 million men age 50 and over are affected by dry eye. The occurrence of dry eye increases with age. SERI reports that nearly 75 percent of people over age 65 will experience dry eye syndrome6, and the condition occurs most often in older women after menopause. As the number of ocular disorders increases, the demand for the eye drops increases and the demand for the ophthalmology packaging also increases.

Furthermore, innovations in packaging technology are helping to drive the expansion of this market. Consumers concerned with safety and efficacy are increasingly turning to innovations like preservative-free formulations and user-friendly delivery technologies. These advancements not only improve patient compliance, but also reflect emerging trends toward environmentally responsible packaging alternatives. As manufacturers invest in R&D to develop smarter and more sustainable packaging alternatives, the eye drops segment will continue to capitalize on improved product offerings that fulfills evolving demands from customers. For instance, in November 2024, Berry Global launched a new 'easy-squeeze' ophthalmic 10ml bottle that has been approved for use with Aptar Pharma's Ophthalmic Squeeze Dispenser (OSD), a solution for preservative-free product such as eye treatments.

Geographical Analysis

North America is expected to hold a significant position in the global ophthalmology packaging market share

The dominance of the North American market in the global ophthalmology packaging market is due to various factors such as advanced healthcare infrastructure, robust healthcare infrastructure, technological advancements, high prevalence of ocular diseases, strategic partnerships, increasing export of ophthalmic products, product launches and approvals, and increasing adoption of innovative medical technologies.

The increasing prevalence of ocular disorders in this region increases the demand for ophthalmology packaging. For instance, according to Dry Eye Directory, currently between 16.7 million and 50.2 million Americans have dry eyes. This is between 5-15% of the population. Dry Eye Disease in the USA costs over $55.4 billion to the economy each year. A large population study of over 79,866 people in Netherlands found that 9.1% had dry eye disease. Moreover, according to the Centers for Disease Control and Prevention, an estimated 9.6 million people in the United States were living with diabetic retinopathy. There were 8.94 million people aged >=40 years with DR and 1.71 million people aged >=40 years with vision threatening DR. The prevalence rate was higher among males than females for DR (0.64% vs. 0.47%) and vision-threatening DR (2.74% vs 1.94%). As the number of ocular disorders increases, the demand for the ophthalmology packaging increases and the demand for the ophthalmology packaging also increases.

Furthermore, the increased export of ophthalmic products from North America contributes significantly to the region's market share growth. As North American organizations create innovative packaging solutions that match international requirements, they will be better positioned to take a larger share of the worldwide market. The emergence of internet shopping creates new prospects for growth, as customers seek easy access to eye care products via e-commerce platforms. This transition needs safe and economical packaging solutions that can resist shipping and handling while preserving product integrity.

Asia Pacific is growing at the fastest pace in the global ophthalmology packaging market

The Asia Pacific region is emerging as the fastest-growing market for ophthalmology packaging, owing to a combination of demographic trends, increased healthcare investment, recent launches, and an increasing prevalence of ocular diseases.

The increasing prevalence of ocular diseases is one of the factors that drive the market in this region. For instance, according to the National Institute of Health, according to a survey, India has an unmet need of more than 22 million blind eyes (12 million blind persons), with cataracts accounting for 80.1% of these cases. The annual incidence of cataract blindness is around 3.8 million. The current annual level of performance is approximately 1.6-1.9 million cataract surgeries. To clear the holdup of cataract cases and address the rising incidence, 5-6 million cataract procedures will be conducted yearly, rising to the current rate of 1.7 million per year.

One of the key drivers of this growth has been the rise of the pharmaceutical manufacturing sector in Asia-Pacific countries. Countries such as China and India are emerging as major players in the global pharmaceutical scenario, because of huge investments in healthcare infrastructure and manufacturing skills. The increased manufacturing of ophthalmic products, combined with a greater emphasis on innovative packaging technologies, is expected to fulfill the growing need for eye care solutions. For instance, adding smart packaging features like tamper-evident seals and user-friendly dispensing systems improves patient compliance and safety, making these items more desirable to consumers.

Competitive Landscape

The major global players in the global ophthalmology packaging market include Amcor plc, West Pharmaceutical Services, Inc., Gerresheimer AG, Schott AG, AptarGroup, Inc., Johnson & Johnson Services, Inc., Bausch + Lomb, Aerie Pharmaceuticals, Inc., Merck & Co., Inc., Akorn Operating Company LLC among others.

Emerging Players

Dou Yee Enterprises, Schott AG, and Bormio Pharma among others

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global ophthalmology packaging market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Packaging Type
3.2. Snippet by Application
3.3. Snippet by Indication
3.4. Snippet by Dosage
3.5. Snippet by Material
3.6. Snippet by End-User
3.7. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.2. Increasing Demand for Ophthalmology Packaging
- 4.1.3. Restraints
- 4.1.4. High Production Costs
- 4.1.5. Opportunity
- 4.1.6. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Packaging Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 6.1.2. Market Attractiveness Index, By Packaging Type
6.2. Tubes*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Bottles
6.4. Syringes
6.5. Flexible Pouches
6.6. Ampoules
6.7. Vials

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Eye Drops*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Ophthalmology Gels
7.4. Ophthalmology Ointment
7.5. Anti-VEGF Drugs

8. By Indication

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 8.1.2. Market Attractiveness Index, By Indication
8.2. Refractive Errors*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Cataracts and Glaucoma
8.4. Retinal Disorders
8.5. Corneal Diseases
8.6. Pediatric Ophthalmology
8.7. Other

9. By Dosage

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
- 9.1.2. Market Attractiveness Index, By Dosage
9.2. Multi-Dose*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Single-Dose

10. By Material

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 10.1.2. Market Attractiveness Index, By Material
10.2. Glass*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Plastic
10.4. Others

11. By End User

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.1.2. Market Attractiveness Index, By End User
11.2. Pharmaceutical Companies*
- 11.2.1. Introduction
- 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Medical Device Manufacturers
11.4. Healthcare Providers

12. By Region

12.1. Introduction
- 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 12.1.2. Market Attractiveness Index, By Region
12.2. North America
- 12.2.1. Introduction
- 12.2.2. Key Region-Specific Dynamics
- 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
- 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.2.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 12.2.10. The U.S.
- 12.2.11. Canada
- 12.2.12. Mexico
12.3. Europe
- 12.3.1. Introduction
- 12.3.2. Key Region-Specific Dynamics
- 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
- 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.3.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.3.10. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 12.3.11. Germany
- 12.3.12. UK
- 12.3.13. France
- 12.3.14. Italy
- 12.3.15. Spain
- 12.3.16. Rest of Europe
12.4. South America
- 12.4.1. Introduction
- 12.4.2. Key Region-Specific Dynamics
- 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
- 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.4.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 12.4.10. Brazil
- 12.4.11. Argentina
- 12.4.12. Rest of South America
12.5. Asia-Pacific
- 12.5.1. Introduction
- 12.5.2. Key Region-Specific Dynamics
- 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
- 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.5.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 12.5.10. China
- 12.5.11. India
- 12.5.12. Japan
- 12.5.13. South Korea
- 12.5.14. Rest of Asia-Pacific
12.6. Middle East and Africa
- 12.6.1. Introduction
- 12.6.2. Key Region-Specific Dynamics
- 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
- 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
- 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dosage
- 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
- 12.6.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis

14. Company Profiles

14.1. Amcor plc*
- 14.1.1. Company Overview
- 14.1.2. Product Portfolio and Description
- 14.1.3. Financial Overview
- 14.1.4. Key Developments
14.2. West Pharmaceutical Services, Inc.
14.3. Gerresheimer AG
14.4. Schott AG
14.5. AptarGroup, Inc.
14.6. Johnson & Johnson Services, Inc.
14.7. Bausch + Lomb
14.8. Aerie Pharmaceuticals, Inc.
14.9. Merck & Co., Inc.
14.10. Akorn Operating Company LLC

LIST NOT EXHAUSTIVE